CPHI icon

China Pharma Holdings
CPHI

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $212K invested in China Pharma Holdings in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$109K
2
+$31.8K
3
+$23.7K
4
TRCT
Tower Research Capital (TRC)
New York
+$14.7K

Top Sellers

1
-$22K
2
-$12.1K
3
-$6.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$128K
Citadel Advisors
2
Citadel Advisors
Florida
$41.3K
HF
3
HRT Financial
New York
$28K
TRCT
4
Tower Research Capital (TRC)
New York
$14.7K
XT
5
XTX Topco
Cayman Islands
–
Renaissance Technologies
6
Renaissance Technologies
New York
–
TSS
7
Two Sigma Securities
New York
–